HNRNPR

Across TCGA pan-cancer cohorts, HNRNPR mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated HNRNPR data layer compared with 22 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher HNRNPR mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated HNRNPR expression acts as an unfavorable survival marker, although some lineages such as LUAD and CCRCC show a favorable association.

HNSC, LUAD, and CCRCC are the cancer types where HNRNPR mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	II,III,IV	0.585	0.891	<.001	73	view →
LUAD	DFS	Tertile	All	1.000	0.647	.003	10	view →
CCRCC	DFS	Tertile	III,IV	0.776	0.425	.047	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

HNRNPR–HNSC (OS)

Open the HNSC breakdown →